Combination intravitreal anti-vascular endothelial growth factor inhibitors and macular laser photocoagulation relative to intravitreal injection monotherapy in macular oedema secondary to retinal vein occlusion: a meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Combination intravitreal anti-vascular endothelial growth factor inhibitors and macular laser photocoagulation relative to intravitreal injection monotherapy in macular oedema secondary to retinal vein occlusion: a meta-analysis of randomized controlled trials

Published:2021-11-24 Issue: Volume: Page:
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Bhambra Nishaant^ORCID,Sayal Aman P.^ORCID,Popovic Marko M.^ORCID,Muni Rajeev H.,Kertes Peter J.

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://www.nature.com/articles/s41433-021-01833-2.pdf

Reference32 articles.

1. Woo SCY, Lip GYH, Lip PL. Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review. Eye. 2016;30:1031–8.

2. Blair K, Czyz CN. Central retinal vein occlusion. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2019. http://www.ncbi.nlm.nih.gov/books/NBK525985/. Accessed 3 Dec 2019.

3. Rhoades W, Dickson D, Nguyen QD, Do DV. Management of macular edema due to central retinal vein occlusion – the role of aflibercept. Taiwan J Ophthalmol. 2017;7:70–6.

4. Gewaily D, Muthuswamy K, Greenberg PB. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion. Cochrane Database Syst Rev. 2015;9:CD007324.

5. Kimoto K, Kubota T. Anti-VEGF agents for ocular angiogenesis and vascular permeability. J Ophthalmol. 2012. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216356/. Accessed 27 Dec 2020.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry;Scientific Reports;2024-03-13

2. 12-month outcomes of treatment-naïve retinal vein occlusion initially treated with either dexamethasone implants or vascular endothelial growth factor inhibitors: Data from the Fight Retinal Blindness! registry;2023-08-01

3. Anti-Vascular Endothelial Growth Factor Treatment Compared with Steroid Treatment for Retinal Vein Occlusion: A Meta-Analysis;Ophthalmologica;2022